Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan, Amlodipine, and HCTZ in Hypertension
NCT01911780Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jul 2013; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01911780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911780.